Difference between revisions of "Part:BBa K3621008:Design"
(One intermediate revision by the same user not shown) | |||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | + | This part was chosen based off computational modeling of cytokine players in the COVID-19 cytokine storm | |
− | + | It was planned and designed online for use in our computational model. See more on the <html> <a href="https://2020.igem.org/Team:MIT/Model">Model Page on the MIT iGEM 2020 wiki. </a> | |
+ | </html> | ||
===Source=== | ===Source=== | ||
− | + | This part was sourced online through the following literature: <html><a href="https://academic.oup.com/peds/article/17/1/95/1571465"> "Identification of potent human anti‐IL‐1RI antagonist antibodies"</a></html> | |
− | + | ||
===References=== | ===References=== |
Latest revision as of 19:08, 27 October 2020
scFv for IL-1
Assembly Compatibility:
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 468
Illegal PstI site found at 631 - 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 468
Illegal PstI site found at 631 - 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 468
Illegal PstI site found at 631 - 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 468
Illegal PstI site found at 631 - 1000COMPATIBLE WITH RFC[1000]
Design Notes
This part was chosen based off computational modeling of cytokine players in the COVID-19 cytokine storm It was planned and designed online for use in our computational model. See more on the Model Page on the MIT iGEM 2020 wiki.
Source
This part was sourced online through the following literature: "Identification of potent human anti‐IL‐1RI antagonist antibodies"